Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
16.89
-0.01 (-0.06%)
Apr 30, 2026, 2:35 PM CST

SHE:002932 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-75.0674.5274.934,2081,413
Depreciation & Amortization
54.3862.9883.459.0823.63
Other Amortization
1.0214.5111.822.650.87
Loss (Gain) From Sale of Assets
-0.66-1.79-0.31-0.01-
Asset Writedown & Restructuring Costs
14.4287-4.58646.5621.33
Loss (Gain) From Sale of Investments
-104.83-135.44-125.14-37.88-0.67
Other Operating Activities
66.74-47.283.29153.3334.62
Change in Accounts Receivable
176.21411.721,256-2,325-722.32
Change in Inventory
35.3184.76342.82-473.38-166.86
Change in Accounts Payable
-244.39-644.14-1,3021,539530.21
Change in Other Net Operating Assets
-4.0179.95370.01-
Operating Cash Flow
-70.05-85.05392.54,0131,127
Operating Cash Flow Growth
---90.22%256.06%213.33%
Capital Expenditures
-90.89-184.77-109.97-313.38-103.57
Sale of Property, Plant & Equipment
4.170.780.15--
Divestitures
0.84----
Investment in Securities
449.6528.04-1,290-1,958-588
Other Investing Activities
66.1517.8234.7137.186.45
Investing Cash Flow
429.91-138.12-1,365-2,234-685.12
Short-Term Debt Issued
-323.61137.3930
Total Debt Issued
-323.61137.3930
Short-Term Debt Repaid
--23.61-125-53.42-141.5
Long-Term Debt Repaid
-3-6-20.49-4.72-2.95
Total Debt Repaid
-3-29.61-145.49-58.14-144.45
Net Debt Issued (Repaid)
-3-26.61-121.8779.24-114.45
Issuance of Common Stock
----482.71
Repurchase of Common Stock
--238.16-0.53--
Common Dividends Paid
-263.26-47.39-582.48-550.64-283.39
Other Financing Activities
-18.09-1.0134.8338.6-2.6
Financing Cash Flow
-284.35-313.17-670.06-432.7982.27
Foreign Exchange Rate Adjustments
-1.550.511.2619.47-3.2
Net Cash Flow
73.95-535.83-1,6411,365520.96
Free Cash Flow
-160.95-269.81282.523,6991,023
Free Cash Flow Growth
---92.36%261.47%208.82%
Free Cash Flow Margin
-60.72%-77.08%37.69%35.13%36.17%
Free Cash Flow Per Share
-0.68-1.201.2416.094.84
Cash Income Tax Paid
14.774.45268.91,253219.86
Levered Free Cash Flow
--188.62281.922,660631.65
Unlevered Free Cash Flow
--187.81288.492,662632.97
Change in Working Capital
-26.07-139.55349.09-1,019-365.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.